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                                                                       ABSTRACT 
Introduction 
The study aimed to assess and improve the quality of care for Opuwo District Hospital HIV/AIDS 
clinic in Namibia.  Currently, there is no literature available on the quality of care for the HIV/AIDS 
clinic at primary level in Namibia. 
Opuwo District has one of the lowest prevalence rates of HIV/AIDS in Namibia with 8.8% among 
ANC patients. A total of 1714 HIV positive patients are enrolled at Opuwo District Hospital 
HIV/AIDS clinic and 109 (6.36%) of them are defaulting treatment.  Based on these statistics, I 
decided to do a quality improvement cycle of the HIV clinic system to see if it would improve 
adherence. Adherence will improve if the quality of care rendered to patients is standard (18). 
 
Aim and Objectives 
The aim of the research is to improve the quality of care for patients on ARVs, with concern for 
factors influencing adherence in Opuwo district Hospital. 
The objectives are as follow: 
1) To evaluate the quality of care that was given to patient registered at  Opuwo HIV/AIDS 
clinic since 2007 
2) To correct inadequacies discovered during initial evaluation of the clinic to improve the 
quality of care 
3) To evaluate if corrected inadequacies have led to improved quality 
 
Method 
The study design is a quality improvement cycle 
The quality improvement cycle done was a teamwork that involved trained nurses in HIV, data clerk, 
counsellors, trained pharmacist in ARV therapy and a doctor. This team audited care rendered by 
looking at the structure, process and outcome of the care given at the clinic; then inadequacies 
discovered were corrected and the whole system was re-audited to see if there is improvement. 
The study population was patients attending HIV/AIDS clinic since 2007 until date and the sample 
size was fifty with selection made by random sample using simple proportion (HIVQUAL system that 
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was automatically programmed to calculate sample size based on the population of patients entered 
into the system). 
Data on structure was carried out prospectively by observing what is on the ground in term of 
equipment, staff, tools etc. Data for proper documentation, weight checked at every visit, clinical 
staging at every visit, counselling at every visit, TB screening etc and outcome (regular in clinic 
attendance, viral load below 1000 after 6months on HAART, etc) were audited retrospectively using 
patient’s file. 
Results 
Using chi-square test to analyse the data, the intervention was successful because the P-values were 
less than 0.05 in most of the indicators audited for process and outcome. 
It was found that after the intervention (in-service training, re-enforce proper documentation, re-
enforce health education by all staff not limit it to counsellors alone, wall poster to remind staff on 
ordering investigation for CD4, viral load when due and follow up results by doctor or nurses, weigh 
check for all patients before starting consultation, doctor and nurses should prescribe IPT, Co-
trimoxazole and multivitamins) was made, adherence improved from 46% to 82% and opportunistic 
infection declined below 15%. 
Conclusion 
The quality improvement cycle enabled simple changes like in-service training, re-enforcement of 
health education by all staff, etc to be made at the clinic, which lead to appreciable quality 
improvement over a short period.  
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                                                                 Chapter 1 
                                INTRODUCTION, BACKGROUND AND MOTIVATION 
Human immunodeficiency virus (HIV) belongs to the retrovirus family called Lentivirus that causes 
acquired immunodeficiency syndrome (AIDS) (1) (2). WHO has declared HIV infection in humans as 
pandemic, and contentment about it may play a key role in HIV risk (3) (4). Since its discovery in 
1981, AIDS have killed more than 25 million people worldwide (5). HIV infects about 0.6% of the 
world's population (5). In 2009, AIDS claimed an estimated 1.8 million lives, down from a global 
peak of 2.1 million in 2004 (6). Approximately 260,000 children died of AIDS in 2009(6). A 
disproportionate number of AIDS deaths occur in Sub-Saharan Africa, retarding economic growth and 
exacerbating the burden of poverty (7). An estimated 22.5 million people (68% of the global total) 
live with HIV in sub-Saharan Africa, which is also home to 90% of the world's 16.6 million children 
orphaned by HIV (6). Treatment with antiretroviral drugs reduces both the mortality and the 
morbidity of HIV infection (8). 
Namibia is one of the countries hit by the HIV epidemic with the prevalence among pregnant women 
attending ANC in the country standing at 17.8% in 2010(9). HIV in Namibia is primarily transmitted 
through heterosexual transmission. The Government of Namibia has been monitoring HIV prevalence 
since 1992 through sentinel surveillance of pregnant at selected antenatal facilities throughout the 
country (9). 
Opuwo district has one of the lowest prevalence of HIV/AIDS in Namibia at 8.8%. At the moment 
736 patients are on free HAART, courtesy of the government and foreign donors. Despite the free 
treatment and availability of medication, the number of HAART defaulters in the district is alarming 
and as at January 2012, stands at 109 patients. This data from Opuwo State Hospital’s HIV Clinic is a 
wakeup call to the risk of treatment failure and the development of widespread HIV (Human 
Immunodeficiency Virus) resistance strain unless all patients are given the continuing support they 
need to achieve full adherence to ARV’s. 
Overview of the literature  
 The quantity rather than quality of health services has been the focus historically in developing 
countries and ample evidence suggests that quality of care (or the lack of it) must be at the centre of 
every discussion about better health (10). 
In the same way clinical aspects of care are routinely reviewed and changed, the HIV quality program 
needs to be continuously and systemically evaluated and improved (11). 
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The necessity for quality and safety improvement initiatives permeates health care. Lohr and 
Schroeder define quality health care as the degree to which health services for individual and 
populations increase the likelihood of desired health outcomes and are consistent with current 
professional knowledge (12). 
According to the Institute of Medicine (IOM) report, To Err Is Human, the majority of medical errors 
result from faulty system and processes, not from individuals (13). Processes that are inefficient and 
variable, changing case mix of patients, health insurance, differences in provider education and 
experience, and numerous other factors contribute to the complexity of health care. With this in mind, 
the IOM also asserted that today’s health care industry function at a lower level than it can and 
should. 
The following examples are illustrative: In one study, evaluating paediatric care in Papua New 
Guinea, 69 percent of health centre workers reported that they checked for only two of the four 
examination criteria for pneumonia cases (14). Only 24 percent of these workers were able to indicate 
correct treatment for malaria. When clinical encounters were observed at aid posts, providers met 
minimal examination criteria in only 1 percent of cases.  
In a study in Pakistan, only 56 percent of providers met an acceptable diagnostic standard for viral 
diarrhoea and only 35 percent met the acceptable standard for treatment (15). 
The concept of quality is one of the leading forces in improving health services. According to Tamura 
and Perriens, The International Organization for Standardization (ISO) defines quality as “the totality 
of features and characteristics of an entity that bears on its ability to satisfy a stated or implied need” 
(16). 
Hardon stated that ‘AIDS is particularly challenging because of the need to achieve very high (at least 
95%) levels of adherence to prevent treatment failure and the generation of ARV resistance’ (17). In 
this study, adherence means compliance to the demands of ART/ARV (18). 
Reiter and Gary emphasised that adherence will improve if quality of care rendered to patients is good 
(18). A number of factors are associated with adherence to ART and are commonly divided into five 
intersecting categories. These categories are patients’ variables, treatment regimens, disease 
characteristics, patients-provider relationship and clinical setting (18). 
Rabkin, El- Sadr, and Abrahams; described adherence as engagement and accurate participation of an 
informed patient in a plan of care’ (19). They further stated that ‘The concept of ‘adherence’ has a 
broader meaning than compliance which encompasses the extent to which a patient follows 
instructions, implying understanding, consent and partnership (19). It also includes entering into and 
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continuing in a programme, or care plan, notably, meeting appointment and tests as scheduled. 
Adherence to treatment encompasses more than adherence to medications, rather encompasses regular 
clinic attendance, etc. 
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                                                                   Chapter 2 
      METHODS 
Aim 
To improve the quality of care for patients on ARVs, with the concern for factors influencing 
adherence in Opuwo State Hospital 
Objectives  
1) To evaluate the quality of care that was given to patient registered at  Opuwo HIV/AIDS 
clinic since 2007 
2) To correct inadequacies discovered during initial evaluation of the clinic to improve the 
quality of care 
3) To evaluate if corrected inadequacies have led to improved quality 
Study design 
The study design is a quality improvement cycle. 
Setting Target of Standard 
The criteria used in setting the targeted standard are based on Namibia HIV monitoring indicators; the 
team agreed that all indicators should have at least 90% and opportunistic infection to decline to 15%. 
Quality Improvement Cycle (QIC) Team 
The quality improvement team comprised of the HIV/AIDS doctor, the pharmacist attached to the 
HIV/AIDS Clinics, two HIV/AIDS clinic nurses (1 registered nurse and 1 enrolled nurse), the clinic 
data clerk, counsellors and myself. 
Quality of service can be improved using the quality improvement cycle, which consists of five 
essential steps: 
1) Agree criteria( set target standard) 
2) Observe practice(collect data) 
3) Evaluate information 
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4) Implement invention 
5) Re-audit  
The Setting 
The study took place in Opuwo district hospital, Kunene region health directorate in the Republic of 
Namibia. The district has a 90 beds capacity hospital, two health centres, 13 Primary Health Care 
Clinics and ninety-one outreach points. The total district population is 49,018. The study took place in 
Opuwo state hospital because the HIV/AIDS clinic is situated in this hospital. HIV prevalence rate by 
ANC sentinel surveillance in Opuwo is 8.8% of population of women attending the ante-natal clinic 
in Namibia. 
 
Study Population: 
The study is on the entire HIV/AIDS clinic system in Opuwo District Hospital and population will be 
the people living with human immunodeficiency virus (HIV) that registered in Opuwo HIV/AIDS 
clinic. 
Data Collection 
Sample size was 50 and was determined by HIVQUAL software. The sample size confidence interval 
was 95% and selection was by random sampling. 
Data on equipment, staff, tools, etc were carried out prospectively. 
The doctor using Excel spreadsheet collected data for the process like proper documentation, 
counselling on adherence, etc prospectively. 
The outcome data was assessed by checking the folder of all patients attending HIV/AIDS clinic to 
see how many of them defaulted treatment,  how many of them have their Viral Load below 1000 
after 6months of HAART, number of patients that completed 6months of IPT and patients with 
opportunistic infections.  
 
Evaluate Information 
Baseline data analyses and results were shared with the HIV quality committee. 
The summaries of performance measurement data include graphics such as tables or charts. 
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The analysis began with a few questions or hypotheses before spending too much time digging 
through the data. Data from the audit was analyzed using simple frequencies / percentages .The 
display of data results is limited to summaries of the most important findings. 
 
 
PLAN CARE AND IMPLEMENT CHANGE 
Planning Change 
Discussion with these key role-players was conducted as to what changes could realistically be 
implemented. Questions posed included: “Did we meet our goal? What worked and what did not 
work? Do we need additional test cycle?” 
The following elements are helpful to maintain long-term effects of implemented gains: re-measure 
performance level, educate staff to support improvements, identify a champion of change, ensure 
ownership of change and institutionalize changes (11). 
Implementation of change 
The team was briefed and a plan of action was collectively decided on, a period of approximately six 
months was given for the changes to be implemented.  
Favourable risk-benefit ratio 
There is no risk involved but rather benefit, because we cannot continue to do things in the old 
incorrect way. When assessing our services and implementing change, it will benefit the patients 
immediately and the community in the long run.  
Independent review 
Ethics approval was granted by HREC (Human Research Ethics Committee) before proceeding with 
the research and from the Namibian Ministry of Health and Social Services to use HIV/AIDS clinic 
for collection of data.  
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Chapter 3 
RESULTS ANALYSIS 
STRUCTURE 
The researcher walking through the facility and observing the items listed on Table 3.1on 5 days of 
data collection audited the structural criteria. 
A total of 50 patients had their file audited, 18(36%) are males and 32(64%) are females 
The table 3.1 shows the result of the audit as at 30
th
 October 2012 of the structural audit. 
Table 3.1 –Structural Assessment 
Does the clinic have an isolated building? 
 
No isolated building for patients living with 
HIV/AIDS 
Does the clinic have trained personnel? 
 
Yes, one registered Nurse, one enrolled Nurse, a 
Data clerk, counsellors and pharmacy assistant. 
All of them are trained in HIV/AIDS. But there is 
no doctor for the clinic specifically 
Does the clinic have a pharmacy department? 
 
Yes 
Does the clinic have a functioning computer for 
data storage? 
 
Yes, there is a computer and a printer 
Does the clinic have charts to counsel clients? 
 
Yes 
Is the appropriate medication in stock on the day 
of the audit? 
Yes 
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Does the clinic have a separate HIV testing 
room? 
 
No direct testing room in the clinic, patient have 
to go out of the clinic to nearby testing room. 
Trained members of staff adequate for patient 
numbers? 
 
 
PROCESS 
Table 3.2 show the initial audit result, and only four indicators met the standard of good quality of 
care because they scored more than 90%.  This audit was done by reviewing the patients’ file. 
Table 3.2-Initial Process Assessment 
INDICATOR INITIAL AUDIT   PERCENTAGE  OF 
INITIAL AUDIT 
Proper documentation 22 42% 
weight checked at every visit 44 88% 
Clinical staging at every visit 49 98% 
Counselling at every visit 50 100% 
TB screening at every visit 48 96% 
Alcohol screening at every visit 44 88% 
Assessment of quality and 
quantity of nutritional intake 
41 82% 
Patient Qualify for HAART 
 
42 84% 
Patient Qualify for HAART and 
started on HAART 
33 66% 
Viral load checked every 
6months of HAART 
3 6% 
CD4 Count checked 6 months 
after HAART Initiation 
1 2% 
Given INH prophylaxis 18 36% 
Use Contraceptives 44 88% 
On Co-trimoxazole prophylaxis 45 90% 
On multivitamins 43 86% 
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serum creatinine checked at 3 
months 
0 0% 
serum creatinine checked at 6 
months 
0 0% 
serum creatinine checked every 
6 months 
0 0% 
 
 
OUTCOME 
Table 3.3 outcome assessment 
Indicator Baseline((Initial Assessment)  Baseline((Initial Assessment) 
percentage 
Regular in clinic attendance 23 46% 
Viral load below 1000 after 
6months on HAART 
2 4% 
Patients that completed 
6months of IPT 
10 20% 
Patients with opportunistic 
infection 
23 46% 
 
 
Plan and implement changes to improve the quality of care for HIV/AIDS 
The initial audit findings were presented to the audit team on 30
th
 October 2012, only four indicators 
met the set standard. Discussion with the team was conducted as to what changes could realistically 
be implemented. 
The team welcomed the findings and voiced their limitations and concerns; 
 Time constraints: the individual health care providers have to see a large number of patients 
daily, thus they cannot spend more than 10 minutes with a patient. 
 Dwindling staff members: vacant posts are not being filled, or the posts are being frozen, thus 
resulting in increasing pressure on the existing staff. The trend was observed by the family 
physician and applied to both nursing staff and doctors. 
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 Increasing patient population: despite a shortage of staff members the patient population is 
increasing. 
 Patient 
adherence to treatment: often a problem despite a perception that patient health care education 
was adequate. 
 
INTERVENTIONS 
● Re-enforce proper documentation. 
●Re-enforce health education by all staff not limit it to counsellors alone. 
●Wall poster to remind staff on ordering investigation for CD4, viral load when due and follow up 
results by doctor or nurses. 
●Weigh check for all patients before starting consultation 
●In service training 
●Doctor and nurses should prescribe IPT, Co-trimoxazole and multivitamins 
However, the team agreed to improve on the care of patients and to implement changes within six 
months period of 1
st
 November 2012 to 30
st
 April 2013. In January 2013 re-enforcement of changes 
implement was carried out and re-auditing was carried out in the first week of May 2013. 
Regarding the structure, the team had no power to effect any change, because staff recruitment and 
buildings are the responsibility of the ministry of health. However, hospital management was 
consulted to remind/inform  them about the structural challenges. 
The post-intervention medical audit included all the patients from the baseline audit of 1
st
 November 
2012 to 30
th
 April 2013. The total number of folders that were re-audited was 47; the remaining three 
could not be located 
Table 3.4 compares the percentage of initial audit, re-audit for the process, and out of 18 indicators 
looked at, there was improvement in 16(The intervention was successful because the P-value is less 
than 0.05) and the two without improvement are indicators that nothing tangible could correct the 
indicators in question  at the time of auditing. 
 
Table 3.4a Final process  
Indicators Initial Audit Re-audit after 
6months 
P-value 
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Proper 
documentation 
42% 77% 0.00045 
weight checked at 
every visit 
88% 92% 0.15506 
Clinical staging at 
every visit 
98% 96% 0.24789 
counselling at 
every visit 
100% 96% 0.10096 
TB screening at 
every visit 
96% 96% 0.00391 
Alcohol screening 
at every visit 
88% 96% 0.16494 
Assessment of 
quality and 
quantity of 
nutritional intake 
82% 86% 0.12838 
Patient Qualify 
for HAART 
84% 88% 0.02723 
Patient Qualify 
for HAART and 
started on 
HAART 
66% 80% 0.00003 
Viral load 
checked every 6 
months of 
HAART 
6% 38% 0.00000 
CD4 Count 
checked 6months 
after HAART 
Initiation 
2% 74% 0.01958 
Given INH 
prophylaxis 
36% 56% 0.04788 
Use 
Contraceptives 
88% 94% 0.00001 
On Co-
trimoxazole 
90% 60% 0.00176 
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prophylaxis 
serum creatinine 
checked every  
6months 
0% 48% 0.00000 
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Table3.4b FINAL OUTCOME ASSESSMENT 
 
 
ANALYSIS OF THE DATA 
The data was captured in an Excel spreadsheet and analysed by the Centre for Statistical Consultation 
at the Stellenbosch University. 
The null hypothesis is that there is no difference between before and after the audit. 
Using chi-square test to analysis the data, the intervention was successful because the P-value show in 
table above is less than 0.05 in most of the indicators and the outcome is significant with opportunistic 
infection declined below 15%. 
The general comment is that for indicators that already have high values, the scope for improvement 
is low but for indicators with low values there is room for improvement. This also applied to the 
outcome, as it is not possible to alter what had happened in the initial 6month of starting HAART. 
 
 
 
 
Indicators Initial Audit Re-audit after 
6months 
P-value 
regular in clinic 
attendance 
46% 82% 0.00001 
Viral load below 1000 
after 6months on 
HAART 
4% 4% 0.10096 
that completed 
6months of IPT 
20% 40% 0.01563 
with opportunistic 
infection 
46% 14% 0.00072 
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Table 3.5: 2-way Summary Table: Observed Frequencies of Time | PD 
 
 
Figure 3.1: Time |PD 
Table 3.5 and Figure 3.1 shows the histogram of time and proper documentation; and the P-value 
tested, since P value is less than 0.05 after intervention, the change is statistically significant. 
 
 
Categorized Histogram: time x PD
Chi-square(df=1)=12.30, p=.00045 Fisher exact, one-tailed p=.00050
N
o
 o
f 
o
b
s
time: baseline
58%
42%
0 1
PD
0
5
10
15
20
25
30
35
40
time: 6 months
23%
77%
0 1
PD
Time PD  
0 
PD 
1 
Row 
Totals 
Baseline 29 21 50 
Row % 58.00% 42.00%  
6 months 11 36 47 
Row % 23.40% 76.60%  
Totals 40 57 97 
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Table 3.6: 2-way Summary Table: Observed Frequencies of Time/ WCAEV 
 
 
 
Figure 3.2: Time | WCAEV 
 
Table 3.6 and Figure 3.2 shows the histogram of time and WCAEV; and the P-value tested, since P 
value is more than 0.05 after intervention, the change is not statistically significant. 
Categorized Histogram: time x WCAEV
Chi-square(df=1)=2.01, p=.15612 Fisher exact, one-tailed p=.15506
N
o
 o
f 
o
b
s
time: baseline
12%
88%
0 1
WCAEV
0
5
10
15
20
25
30
35
40
45
50
time: 6 months
4%
96%
0 1
WCAEV
Time WCAEV 0 WCAEV 1 Row 
Totals 
Baseline 6 44 50 
Row % 12.00% 88.00%  
6 months 2 45 47 
Row % 4.26% 95.74%  
Totals 8 89 97 
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Table 3.7 Two way Summary Table: Observed Frequencies Time/CSAEV 
 
 
Figure 3.3 Categorized Histogram: time x CSAEV 
 
 
Table 3.7 and Figure 3.3 shows the histogram of time and CSAEV; and the P-value tested, since P 
value is more than 0.05 after intervention, the change is not statistically significant. 
 
Categorized Histogram: time x CSAEV
Chi-square(df=1)=1.34, p=.24789 Fisher exact, one-tailed p=.51546
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Table 3.8: 2-Way Summary Table: Observed Frequencies of Time/TSAEV 
 
 
Figure 3.4 Categorized Histogram: Time x TSAEV 
Categorized Histogram: time x TSAEV
Chi-square(df=1)=2.69, p=.10096 Fisher exact, one-tailed p=.26310
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Table 3.8 and Figure 3.4 shows the histogram of time and TSAEV; and the P-value tested, since P 
value is more than 0.05 after intervention, the change is not statistically significant. 
 
 
 
 
 
 
 
 
 
Table 3.9-Way Summary Table: Observed Frequencies of Time/ASEV 
 
 
Time ASEV  
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Baseline 6 44 50 
Row % 12.00% 88.00%  
6 months 0 47 47 
Row % 0.00% 100.00%  
Totals 6 91 97 
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Figure 3.5 Categorized Histogram Time x ASAEV  
 
Table 3.9 and Figure 3.5 shows the histogram of time and ASAEV; and the P-value tested, since P 
value is less than 0.05 after intervention, the change is statistically significant. 
 
 
 
 
 
 
 
 
Categorized Histogram: time x ASAEV
Chi-square(df=1)=8.32, p=.00391 Fisher exact, one-tailed p=.01608
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Stellenbosch University  https://scholar.sun.ac.za
20 
 
Table 3.10: 2-Way Summary Table of Observed Frequencies Time | AQQNI 
 
 
 
 
Figure 3.6 Categorized Histogram Time x AQQNI 
 
Table 3.10 and Figure 3.6 shows the histogram of time and AQQN; and the P-value tested, since P 
value is more than 0.05 after intervention, the change is not statistically significant. 
 
 
 
 
Categorized Histogram: time x AQQNI
Chi-square(df=1)=1.93, p=.16494 Fisher exact, one-tailed p=.14158
N
o
 o
f 
o
b
s
time: baseline
18%
82%
0 1
AQQNI
0
5
10
15
20
25
30
35
40
45
time: 6 months
9%
91%
0 1
AQQNI
Stellenbosch University  https://scholar.sun.ac.za
21 
 
 
 
 
 
 
 
Table 3.11: 2-Way Summary Observed Frequencies Time | PQFH 
 
 
 
 
 
Figure 3.7 Categorized Histogram Time x PQFH 
 
Table 3.11 and Figure 3.7 shows the histogram of time and PQFH; and the P-value tested, since P 
value is more than 0.05 after intervention, the change is not statistically significant. 
Categorized Histogram: time x PQFH
Chi-square(df=1)=2.31, p=.12838 Fisher exact, one-tailed p=.11998
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Table 3.12: 2-Way Summary Observed Frequencies Time | PQFHSH 
 
 
Figure 3.8 Categorized Histogram Time x PQFHSH 
 
 
Categorized Histogram: time x PQFHSH
Chi-square(df=1)=4.88, p=.02723 Fisher exact, one-tailed p=.02507
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Table 3.12 and Figure 3.8 shows the histogram of time and PQFHSH; and the P-value tested, since P 
value is less than 0.05 after intervention, the change is statistically significant. 
 
 
 
 
 
 
 
Table 3.13: 2-Way Summary Observed Frequencies Time | VL6mthH 
 
 
 
Categorized Histogram: time x VL6mthH
Chi-square(df=1)=17.75, p=.00003 Fisher exact, one-tailed p=.00004
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Figure 3.9 Categorized Histogram Time x VL6mthH 
Table 3.13 and Figure 3.9 shows the histogram of time and VL6mthH; and the P-value tested, since P 
value is less than 0.05 after intervention, the change is statistically significant 
 
 
 
 
 
 
 
 
Table 3.14: 2-Way Summary Observed Frequencies Time | CD46mthH 
 
 
Categorized Histogram: time x CD46mthH
Chi-square(df=1)=68.01, p=.00000 Fisher exact, one-tailed p=.00000
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Figure 3.10 Categorized Histogram Time xCD46mthH 
 
Table 3.14 and Figure 3.10 shows the histogram of time and CD46mthH; and the P-value tested, since 
P value is less than 0.05 after intervention, the change is statistically significant 
 
 
 
 
 
 
Table 3.15: 2-Way Summary Observed Frequencies Time | GINHP 
 
 
Figure 3.11 Categorized Histogram Time x GINHP 
Categorized Histogram: time x GINHP
Chi-square(df=1)=5.45, p=.01958 Fisher exact, one-tailed p=.01674
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Table 3.15 and Figure 3.11 shows the histogram of time and GINHP; and the P-value tested, since P 
value is less than 0.05 after intervention, the change is statistically significant 
 
 
 
 
 
Table3.16: 2-Way Summary Observed Frequencies Time | UC 
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Totals 7 90 97 
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Figure 3.12 Categorized Histogram Time x UC 
Table 3.16 and Figure 3.12 shows the histogram of time and UC; and the P-value tested, since P value 
is less than 0.05 after intervention, the change is statistically significant 
 
 
 
 
 
 
 
 
Table 3.17: 2-Way Summary Observed Frequencies Time | CTXP 
 
Categorized Histogram: time x UC
Chi-square(df=1)=3.91, p=.04788 Fisher exact, one-tailed p=.06591
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Figure 3.13 Categorized Histogram Time x CTXP 
Table 3.17 and Figure 3.13 shows the histogram of time and CTXP; and the P-value tested, since P 
value is less than 0.05 after intervention, the change is statistically significant 
 
 
 
 
 
Table 3.18: 2-Way Summary Observed Frequencies Time | MVT 
 
 
Categorized Histogram: time x CTXP
Chi-square(df=1)=20.69, p=.00001 Fisher exact, one-tailed p=.00001
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Figure 3.14 Categorized Histogram Time x MVT 
Table 3.18 and Figure 3.14 shows the histogram of time and MVT; and the P-value tested, since P 
value is less than 0.05 after intervention, the change is statistically significant 
 
 
 
 
 
 
 
Table 3.19: 2-Way Summary Observed Frequencies Time | SCrCE6mth 
 
 
Categorized Histogram: time x MVT
Chi-square(df=1)=9.79, p=.00176 Fisher exact, one-tailed p=.00778
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Figure 3.15 Categorized Histogram Time x SCrCE6mth 
Table 3.19 and Figure 3.15 shows the histogram of time and SCrCE6mth; and the P-value tested, 
since P value is less than 0.05 after intervention, the change is statistically significant 
 
 
 
 
 
 
 
Table 3.20: 2-Way Summary Observed Frequencies Time|RCA 
 
 
Categorized Histogram: time x SCrCE6mth
Chi-square(df=1)=35.37, p=.00000 Fisher exact, one-tailed p=.00000
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Figure 3.16 Categorized Histogram Time x RCA 
Table 3.20 and Figure 3.16 shows the histogram of time and RCA; and the P-value tested, since P 
value is less than 0.05 after intervention, the change is statistically significant 
 
 
 
 
 
 
Table3.21: 2-Way Summary Observed Frequencies Time | VL<1000A6mthH 
 
 
Categorized Histogram: time x RCA
Chi-square(df=1)=19.49, p=.00001 Fisher exact, one-tailed p=.00001
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Figure 3.17 Categorized Histogram Time x VL<1000A6mthH 
Table 3.21 and Figure 3.17 shows the histogram of time and VL <10006mthH; and the P-value tested, 
since P value is more than 0.05 after intervention, the change is not statistically significant 
 
 
 
Table3.22: 2-Way Summary 
Observed Frequencies 
Time|C6mthIPT 
 
 
Categorized Histogram: time x VL<1000A6mthH
Chi-square(df=1)=2.69, p=.10096 Fisher exact, one-tailed p=.26310
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Figure 3.18 Categorized Histogram Time x C6mthIPT 
 
Table 3.22 and Figure 3.18 shows the histogram of time and C6mthIPT; and the P-value tested, since 
P value is less than 0.05 after intervention, the change is statistically significant 
 
 
 
Table3.23: 2-Way Summary Observed 
Frequencies Time|OI 
 
 
 
Categorized Histogram: time x C6mthIPT
Chi-square(df=1)=5.84, p=.01563 Fisher exact, one-tailed p=.01424
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Figure3.19 Categorized Histogram Time x OI 
 
Table 3.23 and Figure 3.19 shows the histogram of time and OI; and the P-value tested, since P value 
is less than 0.05 after intervention, the change is statistically significant 
 
 
 
 
 
 
 
 
 
Categorized Histogram: time x OI
Chi-square(df=1)=11.44, p=.00072 Fisher exact, one-tailed p=.00084
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                                                               Chapter 4 
                                                             DISCUSSION 
Opuwo district has one of the lowest prevalence of HIV/AIDS in Namibia but despite this, the current 
quality of care is poor and needs to be improved. Proper documentation is poor, patients are not 
started on HAART when due, and even when initiated; viral load is not checked at six months after 
starting treatment. INH not given to patient to prevent tuberculosis despite recommended by 
Namibian National Guidelines for Antiretroviral Therapy and part of the indicators for assessment of 
the quality of care render to patient.  It would have been good to know the percentage of patient 
smoking cigarette, but it is not part of the indicators used in Namibia for HIV/AIDS monitoring.  
The results of the audit show improvement in the quality of care, even though not all the indicators 
met the standard. This did not come handy, as the staffs at the clinic were rally round when the initial 
audit finding was concluded. Teamwork and simple changes like re-enforcement in certain areas, 
placement of posters on the wall to remind staffs of some parameters that need to be checked during 
visit etc. 
Comparison with the literature 
Evidence-based guidelines are often under-used in clinical practice (10). The current 
guideline for the management of HIV/AIDS in Namibia is fantastic but not implemented at the 
primary level of care. When the Quality Improvement Team was presented with initial audit 
finding, they all agreed that guideline is not followed in the process of management of the 
patients. The way forward to improve in the use of guidelines include developing it to meet the  
need of the primary health care setup. 
The quality of care provided to control conditions receives considerably less attention (20). This is 
seen in the thesis finding, INH that is given to all HIV patients to reduce incidence of tuberculosis 
have low percentage and also IPT that is too help to reduce opportunistic infections. 
As argued by Wager and Kanouse standard of care activities may affect adherence bahviours and 
clinical outcome (21). Patients attending the clinic know what processes are to be carried out during 
every visit because they were informed through the media. When the normal process of evaluating 
patient when that come to the clinic where carried out after the initial audit, the attendance of patients 
to the clinic improve and the indicators for the outcome after the re-audit also improved and 
opportunistic infections like TB declined; this reflect improvement in the state of patient’s health. 
Studies on drug adherence in the developed world have demonstrated that higher 
levels of drug adherence have been associated with improved virological, immunological 
and clinic outcome and that adherence rates exceeding 95% are necessary in order to 
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maximize the benefit of ART (22)(23).  When attendance increased, opportunistic infection declined  
because when medication is taken regularly viral load decline in the blood and immunity to infection  
improve. clinic attendance increased from 46% to 82%, though did not reach the set standard 
but is vital in general patient’s management. 
Tables 3.4a and 3.4b shows the P-value tested, when the P value is less than 0.05, the change is 
statistically significant and when P-value is more than 0.05, the change is not statistically significant. 
And when the P value is zero, it shows there is no change in the indicator despite intervention. 
 
Limitations and strengths of this study 
The number of patients reduced to 47 after the initial audit, missing files would affect the outcome of 
the data. 
Appreciable improvement would have been achieved, if one or two indicators have 
intervention implement at a time. 
The strength of the study is that there is no inter-observer bias. 
 
Recommendations and implications 
Quality Improvement Cycle is an ongoing process and auditing of Opuwo HIV/AIDS clinic should be 
continuous to maintain high quality of care and sustain the achievement already made through this 
audit. 
With regard to structure, the government should speed up the construction of separate HIV/AIDS 
clinic as in the two other district hospitals in Kunene region; this will bring about needed privacy for 
the patients.  
Staffing at the clinic should be adequate to prevent burnout and stress because the clinic staff 
complain of these during presentation of audit finding. 
Conclusion 
The quality of care at HIV clinic Opuwo is not to the desired standard. The quality improvement cycle 
enabled simple changes to be made at the clinic, which led to appreciable improvement over a short 
period. The audit should be continuous to attain and maintain high quality of care needed for good 
outcome of patients living with HIV/AIDS. 
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